Northwest Biotherapeutics Inc (NWBO)
0.2901
0.00 (0.00%)
USD |
OTCM |
Nov 14, 15:59
Northwest Biotherapeutics Profit Margin (Quarterly): -3.50K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.50K% |
| March 31, 2024 | -6.45K% |
| December 31, 2023 | -4.25K% |
| September 30, 2023 | -4.58K% |
| June 30, 2023 | -7.19K% |
| March 31, 2023 | -1.21K% |
| December 31, 2022 | -4.74K% |
| September 30, 2022 | -15.95K% |
| June 30, 2022 | -6.22K% |
| March 31, 2022 | -3.53K% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -1.73K% |
| December 31, 2020 | -55.73K% |
| September 30, 2020 | -89.86K% |
| June 30, 2020 | -2.90M% |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | -1.07K% |
| June 30, 2019 | 37.69% |
| March 31, 2019 | -6.18K% |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | -7.62K% |
| Date | Value |
|---|---|
| March 31, 2018 | -16.32K% |
| December 31, 2017 | -84.37K% |
| September 30, 2017 | -15.72K% |
| June 30, 2017 | -11.65K% |
| March 31, 2017 | -18.56K% |
| December 31, 2016 | -43.25K% |
| September 30, 2016 | -18.38K% |
| June 30, 2016 | -9.03K% |
| March 31, 2016 | -2.59K% |
| December 31, 2015 | -2.79K% |
| September 30, 2015 | |
| June 30, 2015 | -17.10K% |
| March 31, 2015 | -23.93K% |
| December 31, 2014 | -4.90K% |
| September 30, 2014 | -3.62K% |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | -5.73K% |
| June 30, 2013 | -4.26K% |
| March 31, 2013 | -10.51K% |
| December 31, 2012 | -9.48K% |
| September 30, 2012 | -13.75K% |
| June 30, 2012 | -3.08K% |
| March 31, 2012 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.90M%
Minimum
Jun 2020
-1.21K%
Maximum
Mar 2023
-222.0K%
Average
-5.48K%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -254.8% |
| Operating Margin (Quarterly) | -3.42K% |
| Return on Net Operating Assets | -316.9% |